11:09 AM EST, 01/13/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts started the week off lower late Monday morning, declining 0.58% to 1,291.89 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Ascendis Pharma ( ASND ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which increased 3.7% and 2.9%, respectively. They were followed by furniture maker Natuzzi (NTZ) and petroleum refined Equinor ( EQNR ) , which were up 2.6% and 2.5%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which fell 6.1% and 5.8%, respectively. They were followed by 3D printer company Materialise (MTLS) and semiconductor company Sequans Communications ( SQNS ) , which lost 4.2% and 3.2%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Trinity Biotech ( TRIB ) , which climbed 11% and 4.4%, respectively. They were followed by biopharmaceutical companies Verona Pharma ( VRNA ) and Akari Therapeutics ( AKTX ) , which advanced 3.9% and 2.4%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Mereo BioPharma Group ( MREO ) , which dropped 8.9% and 5.6%, respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were down 4.9% and 4.7%, respectively.